Melanie Wong

3.0k total citations
23 papers, 830 citations indexed

About

Melanie Wong is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Melanie Wong has authored 23 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Infectious Diseases. Recurrent topics in Melanie Wong's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Receptor Mechanisms and Signaling (4 papers) and Cell Adhesion Molecules Research (4 papers). Melanie Wong is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Receptor Mechanisms and Signaling (4 papers) and Cell Adhesion Molecules Research (4 papers). Melanie Wong collaborates with scholars based in United States, United Kingdom and France. Melanie Wong's co-authors include Peter Lockey, Giuseppe A. Papalia, Brian E. Schultz, Hazel J. Dyke, David E. Clark, Vanitha Ramakrishnan, Dennis Norman, Ruth Wang, Roman Sakowicz and Armando G. Villaseñor and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Melanie Wong

23 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Wong United States 17 418 160 156 115 105 23 830
Kathleen M. Gillooly United States 14 263 0.6× 145 0.9× 166 1.1× 146 1.3× 263 2.5× 17 778
John M. Hatcher United States 16 574 1.4× 252 1.6× 211 1.4× 74 0.6× 98 0.9× 33 967
Karl F. Erhard United States 22 772 1.8× 262 1.6× 205 1.3× 100 0.9× 136 1.3× 43 1.4k
Wang‐Qing Liu France 20 805 1.9× 194 1.2× 283 1.8× 95 0.8× 124 1.2× 54 1.2k
Jack A. Kauffman United States 16 416 1.0× 365 2.3× 81 0.5× 58 0.5× 99 0.9× 30 853
Bertrand Leblond France 17 665 1.6× 259 1.6× 142 0.9× 72 0.6× 101 1.0× 29 1.2k
Christine Lambert‐van der Brempt United Kingdom 11 520 1.2× 331 2.1× 243 1.6× 72 0.6× 32 0.3× 20 925
Ron de Jong United States 19 1.1k 2.6× 156 1.0× 289 1.9× 78 0.7× 179 1.7× 33 1.6k
Thomas E. Rawson United States 8 601 1.4× 168 1.1× 262 1.7× 55 0.5× 40 0.4× 17 857
Hongguang Pan United States 9 863 2.1× 98 0.6× 297 1.9× 133 1.2× 133 1.3× 11 1.1k

Countries citing papers authored by Melanie Wong

Since Specialization
Citations

This map shows the geographic impact of Melanie Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Wong more than expected).

Fields of papers citing papers by Melanie Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Wong. The network helps show where Melanie Wong may publish in the future.

Co-authorship network of co-authors of Melanie Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Wong. A scholar is included among the top collaborators of Melanie Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Wong. Melanie Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Appleby, T.C., Ruth Wang, Mariya Morar, et al.. (2019). Protein Footprinting and X-ray Crystallography Reveal the Interaction of PD-L1 and a Macrocyclic Peptide. Biochemistry. 59(4). 541–551. 28 indexed citations
2.
Wong, Melanie, Alexandra B. Samal, Mike Lee, et al.. (2019). The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca2+/CaM. Journal of Molecular Biology. 431(7). 1440–1459. 75 indexed citations
3.
Appleby, T.C., Andrew E. Greenstein, Magdeleine Hung, et al.. (2017). Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9. Journal of Biological Chemistry. 292(16). 6810–6820. 76 indexed citations
4.
Clark, David E., Bohdan Waszkowycz, Melanie Wong, et al.. (2016). Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies. Bioorganic & Medicinal Chemistry Letters. 26(12). 2920–2926. 16 indexed citations
5.
Colley, Helen, Munitta Muthana, Sarah Danson, et al.. (2015). An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. Journal of Medicinal Chemistry. 58(23). 9309–9333. 46 indexed citations
6.
Somoza, John R., David Koditek, Armando G. Villaseñor, et al.. (2015). Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ. Journal of Biological Chemistry. 290(13). 8439–8446. 119 indexed citations
7.
Lad, Latesh, Sheila Clancy, David Koditek, et al.. (2015). Functional Label-Free Assays for Characterizing the in Vitro Mechanism of Action of Small Molecule Modulators of Capsid Assembly. Biochemistry. 54(13). 2240–2248. 7 indexed citations
8.
Boyce, S.E., Neeraj Tirunagari, Anita Niedziela‐Majka, et al.. (2014). Structural and Regulatory Elements of HCV NS5B Polymerase – β-Loop and C-Terminal Tail – Are Required for Activity of Allosteric Thumb Site II Inhibitors. PLoS ONE. 9(1). e84808–e84808. 27 indexed citations
9.
Hung, Magdeleine, Anita Niedziela‐Majka, Debi Jin, et al.. (2013). Large-Scale Functional Purification of Recombinant HIV-1 Capsid. PLoS ONE. 8(3). e58035–e58035. 20 indexed citations
10.
Canales, Eda, Joseph S. Carlson, T.C. Appleby, et al.. (2012). Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(13). 4288–4292. 13 indexed citations
11.
Culp, Patricia, Donghee Choi, Yongke Zhang, et al.. (2010). Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms. Clinical Cancer Research. 16(2). 497–508. 62 indexed citations
12.
Clark, Robin D., Nicholas C. Ray, Karen Williams, et al.. (2008). 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity. Bioorganic & Medicinal Chemistry Letters. 18(4). 1312–1317. 40 indexed citations
13.
Ray, Nicholas C., Robin D. Clark, David E. Clark, et al.. (2007). Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters. 17(17). 4901–4905. 24 indexed citations
14.
Bhaskar, Vinay, Melvin Fox, Melanie Wong, et al.. (2007). Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits. Investigational New Drugs. 26(1). 7–12. 44 indexed citations
15.
Clark, Robin D., Nicholas C. Ray, Paul Blaney, et al.. (2007). 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(20). 5704–5708. 7 indexed citations
16.
Bhaskar, Vinay, Dong Zhang, Melvin Fox, et al.. (2007). A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo. Journal of Translational Medicine. 5(1). 61–61. 66 indexed citations
17.
Dyke, Hazel J., Peter Lockey, Dennis Norman, et al.. (2006). Quinazoline and benzimidazole MCH-1R antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1403–1407. 17 indexed citations
18.
Jackson, Sharon, Thaddeus R. Nieduzak, Guyan Liang, et al.. (2005). Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase. Bioorganic & Medicinal Chemistry. 13(8). 2723–2739. 29 indexed citations
19.
Clark, David E., Hazel J. Dyke, Peter Lockey, et al.. (2004). Structure–activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(15). 4099–4102. 36 indexed citations
20.
Law, Debbie A., Daniel Afar, Vinay Bhaskar, et al.. (2004). Identification and validation of anti-TMEFF2-Auristatin E conjugated antibodies in the treatment of prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 2557–2557. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen M. Gillooly Breakdown of academic impact, for papers by John M. Hatcher Breakdown of academic impact, for papers by Karl F. Erhard Breakdown of academic impact, for papers by Wang‐Qing Liu Breakdown of academic impact, for papers by Jack A. Kauffman Breakdown of academic impact, for papers by Bertrand Leblond Breakdown of academic impact, for papers by Christine Lambert‐van der Brempt Breakdown of academic impact, for papers by Ron de Jong Breakdown of academic impact, for papers by Thomas E. Rawson Breakdown of academic impact, for papers by Hongguang Pan
Rankless by CCL
2026